One year of smokefree bars and restaurants in New Zealand: impacts and responses

BMC Public Health
George Thomson, Nick Wilson

Abstract

New Zealand introduced a smokefree bars and restaurants policy in December 2004. We reviewed the data available at December 2005 on the main public health, societal and political impacts and responses within New Zealand to the new law. Data were collected from publicly available survey reports, and from government departments and interviews. This included data on smoking in bars, attitudes to smokefree bars, bar patronage, socially cued smoking, and perceived rights to smokefree workplaces. The proportion of surveyed bars with smoking occurring decreased from 95% to 3% during July 2004-April 2005. Between 2004 and 2005, public support for smokefree bars rose from 56% to 69%. In the same period, support for the rights of bar workers to have smokefree workplaces rose from 81% to 91%. During the first ten months of the smokefree bars policy, there were only 196 complaints to officials about smoking in the over 9900 licensed premises. The proportion of smokers who reported that they smoked more than normal at bars, nightclubs, casinos and cafés halved between 2004 and 2005 (from 58% to 29%). Seasonally adjusted sales in bars and clubs changed little (0.6% increase) between the first three quarters of 2004 and of 2005, while café an...Continue Reading

References

Jan 1, 1992·British Journal of Addiction·M J JarvisC Feyerabend
Jan 1, 1989·Archives of Dermatological Research·B GuillotJ J Guilhou
Feb 1, 1983·Australian and New Zealand Journal of Medicine·M L FriedlanderM H Tattersall
Jul 28, 1993·JAMA : the Journal of the American Medical Association·M Siegel
Feb 1, 1996·Research in Nursing & Health·K M ConradD Vilnius
Dec 16, 1998·JAMA : the Journal of the American Medical Association·M D EisnerP D Blanc
Jan 1, 1991·Journal of Mental Health Administration·J C Ward, B J Naster
Sep 6, 2000·Nature Medicine·A Dove
Apr 12, 2001·Australian and New Zealand Journal of Public Health·S JonesP Howden-Chapman
Jun 22, 2001·International Journal of Radiation Oncology, Biology, Physics·J Vaarkamp
Mar 23, 2002·Annual Review of Public Health·Ross C BrownsonMelanie A Wakefield
May 30, 2002·Tobacco Control·M N BatesN Garrett
Jul 27, 2002·BMJ : British Medical Journal·Caroline M Fichtenberg, Stanton A Glantz
May 30, 2003·Tobacco Control·T Harper
Feb 20, 2004·Journal of Gambling Studies·Simone RoddaJames G Phillips
May 27, 2004·Health Affairs·Uwe E ReinhardtGerard F Anderson
Mar 1, 2005·Tobacco Control·L L MandelS A Glantz
Mar 26, 2005·Tobacco Control·F Howell
Jul 5, 2005·Australian and New Zealand Journal of Public Health·Alistair WoodwardPapaarangi Reid
Jul 30, 2005·Clinical & Developmental Immunology·Brian W P SeymourLaurel J Gershwin
Sep 30, 2005·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Elizabeth A GilpinJohn P Pierce
Oct 14, 2005·The Journal of the Royal Society for the Promotion of Health·Fiona Milne
Oct 19, 2005·BMJ : British Medical Journal·Shane AllwrightIvan J Perry
Dec 1, 2005·Journal of Health Communication·Michael T Stephenson, Brian L Quick
Dec 29, 2005·American Journal of Public Health·Sara M AbramsLiguo Song
Apr 28, 2006·Journal of General Internal Medicine·Jacqueline R CopeDonna L Washington

❮ Previous
Next ❯

Citations

Oct 31, 2009·International Journal of Public Health·Michael T Halpern, Humphrey Taylor
Aug 21, 2008·Journal of Immigrant and Minority Health·Tamar M J AntinTravis D Satterlund
Dec 15, 2010·Journal of Public Health Policy·Constantine I VardavasYiannis Tountas
Jan 28, 2010·International Journal of Environmental Health Research·Douglas R EadieGerard B Hastings
Apr 10, 2009·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Yi-Hua ChenBor-Cheng Han
May 21, 2009·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Andrew HylandK Michael Cummings
Sep 26, 2006·Tobacco Control·Josh MartinNick Wilson
Feb 5, 2011·Tobacco Control·Carlos Manuel Guerrero LópezHugh R Waters
Aug 20, 2010·BMC Public Health·Nick WilsonHeather Gifford
Sep 1, 2007·BMC Public Health·Iñaki GalánHonorato Ortiz
May 10, 2007·BMC Public Health·Nick WilsonJudy Li
Nov 4, 2006·International Journal for Equity in Health·Nick WilsonMartin Tobias
Apr 9, 2009·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Sherry A McKeeAndrew Hyland
Sep 7, 2011·Scandinavian Journal of Public Health·Antero HelomaAntti Uutela
Aug 4, 2007·Journal of Gambling Studies·Michael Cantinotti, Robert Ladouceur
Jun 15, 2010·BMC Public Health·Michael G BakerNick Wilson
Mar 30, 2018·Journal of Public Health Management and Practice : JPHMP·Elizabeth A SmithRuth E Malone
Feb 24, 2009·Applied Health Economics and Health Policy·Shane Allwright
Oct 24, 2019·International Journal of Environmental Research and Public Health·Yanxia WeiYitian Feng
Jul 18, 2008·Environmental Health Insights·Amanda Niskar

❮ Previous
Next ❯

Software Mentioned

Factiva
Google Scholar

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.